2,042
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

An updated mode of action and human relevance framework evaluation for Formaldehyde-Related nasal tumors

ORCID Icon, , , &
Pages 919-952 | Received 16 Feb 2020, Accepted 19 Nov 2020, Published online: 18 Feb 2021

References

  • Albertini RJ, Kaden DA. 2017. Do chromosome changes in blood cells implicate formaldehyde as a leukemogen? Crit Rev Toxicol. 47(2):145–184.
  • Andersen ME, Clewell HJ, 3rd, Bermudez E, Dodd DE, Willson GA, Campbell JL, Thomas RS. 2010. Formaldehyde: integrating dosimetry, cytotoxicity, and genomics to understand dose-dependent transitions for an endogenous compound. Toxicol Sci. 118(2):716–731.
  • Andersen ME, Clewell HJ, 3rd, Bermudez E, Willson GA, Thomas RS. 2008. Genomic signatures and dose-dependent transitions in nasal epithelial responses to inhaled formaldehyde in the rat. Toxicol Sci. 105(2):368–383.
  • Andersen ME, Gentry PR, Swenberg JA, Mundt KA, White KW, Thompson C, Bus J, Sherman JH, Greim H, Bolt H, et al. 2019. Considerations for refining the risk assessment process for formaldehyde: results from an interdisciplinary workshop. Regul Toxicol Pharmacol. 106:210–223.
  • Aoki Y, Matsumoto M, Matsumoto M, Masumura K, Nohmi T. 2019. Mutant frequency is not increased in mice orally exposed to sodium dichromate. Food Saf (Tokyo). 7(1):2–10.
  • Appelman LM, Woutersen RA, Zwart A, Falke HE, Feron VJ. 1988. One-year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. J Appl Toxicol. 8(2):85–90.
  • Asanami S, Shimono K, Kaneda S. 1998. Transient hypothermia induces micronuclei in mice. Mutat Res. 413(1):7–14.
  • Asanami S, Shimono K, Kaneda S. 2001. Effect of temperature on the frequency of chromosome aberrations and micronuclei in cultured Chinese hamster cells. J Toxicol Sci. 26(5):323–326.
  • ATSDR 1999. Toxicological profile for formaldehyde. Atlanta (GA): U.S. Department of Health and Human Services, Public Health Service.
  • Barnett SD, Buxton ILO. 2017. The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy. Crit Rev Biochem Mol Biol. 52(3):340–354.
  • Beane Freeman LE, Blair A, Lubin JH, Stewart PA, Hayes RB, Hoover RN, Hauptmann M. 2009. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. J Natl Cancer Inst. 101(10):751–761.
  • Berke JH. 1987. Cytologic examination of the nasal mucosa in formaldehyde-exposed workers. J Occup Med. 29(8):681–684.
  • Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. 2006. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol. 36(10):781–792.
  • Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C. 2008. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol. 38(2):87–96.
  • Brooks RA, Gooderham NJ, Edwards RJ, Boobis AR, Winton DJ. 1999. The mutagenicity of benzo[a]pyrene in mouse small intestine. Carcinogenesis. 20(1):109–114.
  • Burgos-Barragan G, Wit N, Meiser J, Dingler FA, Pietzke M, Mulderrig L, Pontel LB, Rosado IV, Brewer TF, Cordell RL, et al. 2017. Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism. Nature. 548(7669):612–612.
  • Campbell JL, Jr., Gentry PR, Clewell Iii HJ, Andersen ME. 2020. A kinetic analysis of DNA-deoxy guanine adducts in the nasal epithelium produced by inhaled formaldehyde in rats-assessing contributions to adduct production from both endogenous and exogenous sources of formaldehyde. Toxicol Sci. 177(2):325–333.
  • Casanova M, Heck HA. 1987. Further studies of the metabolic incorporation and covalent binding of inhaled [3H]- and [14C]formaldehyde in Fischer-344 rats: effects of glutathione depletion. Toxicol Appl Pharmacol. 89(1):105–121.
  • Casanova M, Heck HD, Everitt JI, Harrington WW, Jr., Popp JA. 1988. Formaldehyde concentrations in the blood of rhesus monkeys after inhalation exposure. Food Chem Toxicol. 26(8):715–716.
  • Casanova M, Deyo DF, Heck HD. 1989. Covalent binding of inhaled formaldehyde to DNA in the nasal mucosa of Fischer 344 rats: analysis of formaldehyde and DNA by high-performance liquid chromatography and provisional pharmacokinetic interpretation. Fundam Appl Toxicol. 12(3):397–417.
  • Casanova M, Morgan KT, Gross EA, Moss OR, Heck HA. 1994. DNA-protein cross-links and cell replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde. Fundam Appl Toxicol. 23(4):525–536.
  • Casanova M, Morgan KT, Steinhagen WH, Everitt JI, Popp JA, Heck HD. 1991. Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man. Toxicol Sci . 17(2):409–428.
  • Casanova-Schmitz M, David RM, Heck HD. 1984. Oxidation of formaldehyde and acetaldehyde by NAD+-dependent dehydrogenases in rat nasal mucosal homogenates. Biochem Pharmacol. 33(7):1137–1142.
  • Casanova-Schmitz M, Heck HD. 1983. Effects of formaldehyde exposure on the extractability of DNA from proteins in the rat nasal mucosa. Toxicol Appl Pharmacol. 70(1):121–132.
  • Casanova-Schmitz M, Starr TB, Heck HD. 1984. Differentiation between metabolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]- and [3H]formaldehyde. Toxicol Appl Pharmacol. 76(1):26–44.
  • Chang JC, Barrow CS. 1984. Sensory irritation tolerance and cross-tolerance in F-344 rats exposed to chlorine or formaldehyde gas. Toxicol Appl Pharmacol. 76(2):319–327.
  • Chang JC, Gross EA, Swenberg JA, Barrow CS. 1983. Nasal cavity deposition, histopathology, and cell proliferation after single or repeated formaldehyde exposures in B6C3F1 mice and F-344 rats. Toxicol Appl Pharmacol. 68(2):161–176.
  • Chang JC, Steinhagen WH, Barrow CS. 1981. Effect of single or repeated formaldehyde exposure on minute volume of B6C3F1 mice and F-344 rats. Toxicol Appl Pharmacol. 61(3):451–459.
  • Checkoway H, Dell LD, Boffetta P, Gallagher AE, Crawford L, Lees PS, Mundt KA. 2015. Formaldehyde exposure and mortality risks from acute myeloid leukemia and other lymphohematopoietic malignancies in the US National Cancer Institute cohort study of workers in formaldehyde industries. J Occup Environ Med. 57(7):785–794.
  • Checkoway H, Lees PSJ, Dell LD, Gentry PR, Mundt KA. 2019. Peak exposures in epidemiologic studies and cancer risks: considerations for regulatory risk assessment. Risk Anal. 39(7):1441–1464.
  • Chidiac P, Goldberg MT. 1987. Lack of induction of nuclear aberrations by captan in mouse duodenum. Environ Mutagen. 9(3):297–306.
  • Chiu WA, Guyton KZ, Martin MT, Reif DM, Rusyn I. 2018. Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups. Altex. 35(1):51–64.
  • Cohen SM, Ellwein LB. 1990. Cell proliferation in carcinogenesis. Science. 249(4972):1007–1011.
  • Conolly RB, Kimbell JS, Janszen D, Schlosser PM, Kalisak D, Preston J, Miller FJ. 2003. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Toxicol Sci. 75(2):432–447.
  • Conolly RB, Kimbell JS, Janszen D, Schlosser PM, Kalisak D, Preston J, Miller FJ. 2004. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol Sci. 82(1):279–296.
  • CWF 1984. Report on the consensus workshop on formaldehyde. Environ Health Perspect. 58:323–381.
  • Dalbey WE. 1982. Formaldehyde and tumors in hamster respiratory tract. Toxicology. 24(1):9–14.
  • Dallas CE, Scott MJ, Ward JB, Jr., Theiss JC. 1992. Cytogenetic analysis of pulmonary lavage and bone marrow cells of rats after repeated formaldehyde inhalation. J Appl Toxicol. 12(3):199–203.
  • Danielsson O, Jornvall H. 1992. “Enzymogenesis”: classical liver alcohol dehydrogenase origin from the glutathione-dependent formaldehyde dehydrogenase line. Proc Natl Acad Sci U S A. 89(19):9247–9251.
  • Dingler FA, Wang M, Mu A, Millington CL, Oberbeck N, Watcham S, Pontel LB, Kamimae-Lanning AN, Langevin F, Nadler C, et al. 2020. Two aldehyde clearance systems are essential to prevent lethal formaldehyde accumulation in mice and humans. Mol Cell. https://doi.org/10.1016/j.molcel.2020.10.012
  • Eastmond DA. 2012. Factors influencing mutagenic mode of action determinations of regulatory and advisory agencies. Mutat Res. 751(1):49–63.
  • Eastmond DA, Vulimiri SV, French JE, Sonawane B. 2013. The use of genetically modified mice in cancer risk assessment: challenges and limitations. Crit Rev Toxicol. 43(8):611–631.
  • Edrissi B, Taghizadeh K, Moeller BC, Kracko D, Doyle-Eisele M, Swenberg JA, Dedon PC. 2013. Dosimetry of N6-formyllysine adducts following [¹³C²H2]-formaldehyde exposures in rats. Chem Res Toxicol. 26(10):1421–1423.
  • Edrissi B, Taghizadeh K, Moeller BC, Yu R, Kracko D, Doyle-Eisele M, Swenberg JA, Dedon PC. 2017. N6-formyllysine as a biomarker of formaldehyde exposure: formation and loss of N6-formyllysine in nasal epithelium in long-term, low-dose inhalation studies in rats. Chem Res Toxicol. 30(8):1572–1576.
  • ECHA (European Chemical Agency) 2019. Annex XV Restriction Report. Proposal for a Restriction. Formaldehyde and Formaldehyde Releasers. European Chemicals Agency. Annankatu 18, Helsinki, Finland.
  • EFSA 2006. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to use of formaldehyde as a preservative during the manufacture and preparation of food additives: question No. EFSA-Q-2005-032. EFSA J. 415:1–10.
  • EFSA 2014. Endogenous formaldehyde turnover in humans compared with exogenous contribution from food sources. EFSA J. 12:11.
  • Estonius M, Svensson S, Hoog JO. 1996. Alcohol dehydrogenase in human tissues: localisation of transcripts coding for five classes of the enzyme. FEBS Lett. 397(2–3):338–342.
  • Fabrikant JI, Cherry J. 1970. The kinetics of cellular proliferation in normal and malignant tissues. X. Cell proliferation in the nose and adjoining cavities. Ann Otol Rhinol Laryngol. 79(3):572–578.
  • Farland WH, Lynch A, Erraguntla NK, Pottenger LH. 2019. Improving risk assessment approaches for chemicals with both endogenous and exogenous exposures. Regul Toxicol Pharmacol. 103:210–215.
  • Fenech M, Nersesyan A, Knasmueller S. 2016. A systematic review of the association between occupational exposure to formaldehyde and effects on chromosomal DNA damage measured using the cytokinesis-block micronucleus assay in lymphocytes. Mutat Res. 770:46–57.
  • Fernandez MR, Biosca JA, Pares X. 2003. S-nitrosoglutathione reductase activity of human and yeast glutathione-dependent formaldehyde dehydrogenase and its nuclear and cytoplasmic localisation. Cell Mol Life Sci. 60(5):1013–1018.
  • Feron VJ, Arts JH, Kuper CF, Slootweg PJ, Woutersen RA. 2001. Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol. 31(3):313–347.
  • Fielden J, Ruggiano A, Popovic M, Ramadan K. 2018. DNA protein crosslink proteolysis repair: From yeast to premature ageing and cancer in humans. DNA Repair (Amst). 71:198–204.
  • Fontignie-Houbrechts N. 1981. Genetic effects of formaldehyde in the mouse. Mutat Res. 88(1):109–114.
  • Foster MW, Hess DT, Stamler JS. 2009. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med. 15(9):391–404.
  • Gentry R, Thompson C, Franzen A, Salley J, Albertini R, Lu K, Greene T. 2021. Using mechanistic information to support evidence integration and synthesis: a case study with inhaled formaldehyde and leukemia. Crit Rev Toxicol. https://doi.org/10.1080/10408444.2020.1854678
  • Gocke E, King MT, Eckhardt K, Wild D. 1981. Mutagenicity of cosmetics ingredients licensed by the European Communities. Mutat Res. 90(2):91–109.
  • Golden R, Bus J, Calabrese E. 2019. An examination of the linear no-threshold hypothesis of cancer risk assessment: Introduction to a series of reviews documenting the lack of biological plausibility of LNT. Chem Biol Interact. 301:2–5.
  • Gordon CJ, Spencer PJ, Hotchkiss J, Miller DB, Hinderliter PM, Pauluhn J. 2008. Thermoregulation and its influence on toxicity assessment. Toxicology. 244(2–3):87–97.
  • Grafstrom RC, Curren RD, Yang LL, Harris CC. 1985. Genotoxicity of formaldehyde in cultured human bronchial fibroblasts. Science. 228(4695):89–91.
  • Green LS, Chun LE, Patton AK, Sun X, Rosenthal GJ, Richards JP. 2012. Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. Biochemistry. 51(10):2157–2168.
  • Greenfield RE, Ellwein LB, Cohen SM. 1984. A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer. Carcinogenesis. 5(4):437–445.
  • Gross EA, Swenberg JA, Fields S, Popp JA. 1982. Comparative morphometry of the nasal cavity in rats and mice. J Anat. 135(Pt 1):83–88.
  • Harkema JR, Carey SA, Wagner JG. 2006. The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium. Toxicol Pathol. 34(3):252–269.
  • Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. 2003. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst. 95(21):1615–1623.
  • Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. 2004. Mortality from solid cancers among workers in formaldehyde industries. Am J Epidemiol. 159(12):1117–1130.
  • Heck H, Casanova M. 2004. The implausibility of leukemia induction by formaldehyde: a critical review of the biological evidence on distant-site toxicity. Regul Toxicol Pharmacol. 40(2):92–106.
  • Heck HD, Casanova-Schmitz M, Dodd PB, Schachter EN, Witek TJ, Tosun T. 1985. Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am Ind Hyg Assoc J. 46(1):1–3.
  • Heck HD, White EL, Casanova-Schmitz M. 1982. Determination of formaldehyde in biological tissues by gas chromatography/mass spectrometry. Biomed Mass Spectrom. 9(8):347–353.
  • Hedberg JJ, Hoog JO, Nilsson JA, Xi Z, Elfwing A, Grafstrom RC. 2000. Expression of alcohol dehydrogenase 3 in tissue and cultured cells from human oral mucosa. Am J Pathol. 157(5):1745–1755.
  • Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. 2005. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 6(2):150–166.
  • Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med. 58:295–300.
  • Holmstrom M, Wilhelmsson B, Hellquist H, Rosen G. 1989. Histological changes in the nasal mucosa in persons occupationally exposed to formaldehyde alone and in combination with wood dust. Acta Otolaryngol. 107(1-2):120–129.
  • Horton AW, Tye R, Stemmer KL. 1963. Experimental carcinogenesis of the lung. Inhalation of gaseous formaldehyde or an aerosol of coal tar by C3H mice. J Natl Cancer Inst. 30:31–43.
  • IARC 1995. Wood dust and formaldehyde. IARC monographs on the evaluation of carcinogenic risks to humans 62. Lyon (France): IARC.
  • IARC 2006. Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. IARC monographs on the evaluation of carcinogenic risks to humans 88. Lyon (France): IARC.
  • Iborra FJ, Renau-Piqueras J, Portoles M, Boleda MD, Guerri C, Pares X. 1992. Immunocytochemical and biochemical demonstration of formaldhyde dehydrogenase (class III alcohol dehydrogenase) in the nucleus. J Histochem Cytochem. 40(12):1865–1878.
  • Jensen DE, Belka GK, Du Bois GC. 1998. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem J. 331(Pt 2):659–668.
  • Kamata E, Nakadate M, Uchida O, Ogawa Y, Suzuki S, Kaneko T, Saito M, Kurokawa Y. 1997. Results of a 28-month chronic inhalation toxicity study of formaldehyde in male Fisher-344 rats. J Toxicol Sci. 22(3):239–254.
  • Keller DA, Heck HD, Randall HW, Morgan KT. 1990. Histochemical localization of formaldehyde dehydrogenase in the rat. Toxicol Appl Pharmacol. 106(2):311–326.
  • Kepler GM, Richardson RB, Morgan KT, Kimbell JS. 1998. Computer simulation of inspiratory nasal airflow and inhaled gas uptake in a rhesus monkey. Toxicol Appl Pharmacol. 150(1):1–11.
  • Kerns WD, Pavkov KL, Donofrio DJ, Gralla EJ, Swenberg JA. 1983. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43(9):4382–4392.
  • Kimbell JS, Godo MN, Gross EA, Joyner DR, Richardson RB, Morgan KT. 1997. Computer simulation of inspiratory airflow in all regions of the F344 rat nasal passages. Toxicol Appl Pharmacol. 145(2):388–398.
  • Kimbell JS, Gross EA, Joyner DR, Godo MN, Morgan KT. 1993. Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat. Toxicol Appl Pharmacol. 121(2):253–263.
  • Kimbell JS, Gross EA, Richardson RB, Conolly RB, Morgan KT. 1997. Correlation of regional formaldehyde flux predictions with the distribution of formaldehyde-induced squamous metaplasia in F344 rat nasal passages. Mutat Res. 380(1–2):143–154.
  • Kimbell JS, Subramaniam RP, Gross EA, Schlosser PM, Morgan KT. 2001. Dosimetry modeling of inhaled formaldehyde: comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol Sci. 64(1):100–110.
  • Kleinnijenhuis AJ, Staal YC, Duistermaat E, Engel R, Woutersen RA. 2013. The determination of exogenous formaldehyde in blood of rats during and after inhalation exposure. Food Chem Toxicol. 52:105–112.
  • Kligerman AD, Phelps MC, Erexson GL. 1984. Cytogenetic analysis of lymphocytes from rats following formaldehyde inhalation. Toxicol Lett. 21(3):241–246.
  • Koivusalo M, Baumann M, Uotila L. 1989. Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase. FEBS Lett. 257(1):105–109.
  • Lai Y, Yu R, Hartwell HJ, Moeller BC, Bodnar WM, Swenberg JA. 2016. Measurement of endogenous versus exogenous formaldehyde-induced DNA-protein crosslinks in animal tissues by stable isotope labeling and ultrasensitive mass spectrometry. Cancer Res. 76(9):2652–2661.
  • Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res. 590(1–3):1–280.
  • Leng J, Liu CW, Hartwell HJ, Yu R, Lai Y, Bodnar WM, Lu K, Swenberg JA. 2019. Evaluation of inhaled low-dose formaldehyde-induced DNA adducts and DNA-protein cross-links by liquid chromatography-tandem mass spectrometry. Arch Toxicol. 93(3):763–773.
  • Leung J, Wei W, Liu L. 2013. S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver. Carcinogenesis. 34(5):984–989.
  • Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS. 2001. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 410(6827):490–494.
  • Liu Y, Yu D, Xiao S. 2017. Effects of chronic exposure to Formaldehyde on micronucleus rate of bone marrow cells in male mice. J Pak Med Assoc. 67:933–935.
  • Lu K, Craft S, Nakamura J, Moeller BC, Swenberg JA. 2012. Use of LC-MS/MS and stable isotopes to differentiate hydroxymethyl and methyl DNA adducts from formaldehyde and nitrosodimethylamine. Chem Res Toxicol. 25(3):664–675.
  • Lu K, Collins LB, Ru H, Bermudez E, Swenberg JA. 2010. Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. Toxicol Sci. 116(2):441–451.
  • Lu K, Moeller B, Doyle-Eisele M, McDonald J, Swenberg JA. 2011. Molecular dosimetry of N2-hydroxymethyl-dG DNA adducts in rats exposed to formaldehyde. Chem Res Toxicol. 24(2):159–161.
  • Lu K, Ye W, Zhou L, Collins LB, Chen X, Gold A, Ball LM, Swenberg JA. 2010. Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers. J Am Chem Soc. 132(10):3388–3399.
  • MacGregor JT, Frotschl R, White PA, Crump KS, Eastmond DA, Fukushima S, Guerard M, Hayashi M, Soeteman-Hernandez LG, Johnson GE, et al. 2015. IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat Res Genet Toxicol Environ Mutagen. 783:66–78.
  • Malarkey DE, Bucher JR. 2011. Summary report of the National Toxicology Program and Environmental Protection Agency-sponsored review of pathology materials from selected Ramazzini Institute rodent cancer bioassays. Technical Report. Research Triangle Park (NC): National Toxicology Program.
  • Marsh GM, Youk AO. 2005. Reevaluation of mortality risks from nasopharyngeal cancer in the formaldehyde cohort study of the National Cancer Institute. Regul Toxicol Pharmacol. 42(3):275–283.
  • Marsh GM, Youk AO, Morfeld P, Collins JJ, Symons JM. 2010. Incomplete follow-up in the National Cancer Institute’s formaldehyde worker study and the impact on subsequent reanalyses and causal evaluations. Regul Toxicol Pharmacol. 58(2):233–236.
  • McGregor D, Bolt H, Cogliano V, Richter-Reichhelm HB. 2006. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans. Crit Rev Toxicol. 36(10):821–835.
  • Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. 2003. A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol. 33(6):591–653.
  • Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C. 2014. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol. 34(1):1–18.
  • Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R. 2014. Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol. 34(6):595–606.
  • Meng F, Bermudez E, McKinzie PB, Andersen ME, Clewell HJ, Parsons BL. 2010. Measurement of tumor-associated mutations in the nasal mucosa of rats exposed to varying doses of formaldehyde. Regul Toxicol Pharmacol. 57(2–3):274–283.
  • Merk O, Speit G. 1998. Significance of formaldehyde-induced DNA-protein crosslinks for mutagenesis. Environ Mol Mutagen. 32(3):260–268.
  • Migliore L, Ventura L, Barale R, Loprieno N, Castellino S, Pulci R. 1989. Micronuclei and nuclear anomalies induced in the gastro-intestinal epithelium of rats treated with formaldehyde. Mutagenesis. 4(5):327–334.
  • Miller FJ, Conolly RB, Kimbell JS. 2017. An updated analysis of respiratory tract cells at risk for formaldehyde carcinogenesis. Inhal Toxicol. 29(12–14):586–597.
  • Miller RA, Cesta MF. NTP nonneoplastic lesion atlas: nose, epithelium - metaplasia, squamous. In: Cesta MF, Herbert RA, Brix A, Malarkey DE, Sills RC, editors. National toxicology program nonneoplastic lesion atlas. https://ntp.niehs.nih.gov/nnl/respiratory/nose/epmetasq/index.htm
  • Moeller BC, Lu K, Doyle-Eisele M, McDonald J, Gigliotti A, Swenberg JA. 2011. Determination of N2-hydroxymethyl-dG adducts in the nasal epithelium and bone marrow of nonhuman primates following 13CD2-formaldehyde inhalation exposure. Chem Res Toxicol. 24(2):162–164.
  • Mohner M, Liu Y, Marsh GM. 2019. New insights into the mortality risk from nasopharyngeal cancer in the national cancer institute formaldehyde worker cohort study. J Occup Med Toxicol. 14:4.
  • Monticello TM, Miller FJ, Morgan KT. 1991. Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde. Toxicol Appl Pharmacol. 111(3):409–421.
  • Monticello TM, Morgan KT, Everitt JI, Popp JA. 1989. Effects of formaldehyde gas on the respiratory tract of rhesus monkeys. Pathology and cell proliferation. Am J Pathol. 134(3):515–527.
  • Monticello TM, Swenberg JA, Gross EA, Leininger JR, Kimbell JS, Seilkop S, Starr TB, Gibson JE, Morgan KT. 1996. Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res. 56:1012–1022.
  • Moolgavkar SH, Dewanji A, Venzon DJ. 1988. A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor. Risk Anal. 8(3):383–392.
  • Moolgavkar SH, Knudson AG. Jr. 1981. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 66(6):1037–1052.
  • Morgan DL, Dixon D, King DH, Travlos GS, Herbert RA, French JE, Tokar EJ, Waalkes MP, Jokinen MP. 2017. NTP research report on absence of formaldehyde-induced neoplasia in Trp53 haploinsufficient mice exposed by inhalation. Natl Toxicol Program. 3:1–30.
  • Morgan KT. 1997. A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment. Toxicol Pathol. 25(3):291–307.
  • Morgan KT, Jiang XZ, Starr TB, Kerns WD. 1986. More precise localization of nasal tumors associated with chronic exposure of F-344 rats to formaldehyde gas. Toxicol Appl Pharmacol. 82(2):264–271.
  • Morgan KT, Kimbell JS, Monticello TM, Patra AL, Fleishman A. 1991. Studies of inspiratory airflow patterns in the nasal passages of the F344 rat and rhesus monkey using nasal molds: relevance to formaldehyde toxicity. Toxicol Appl Pharmacol. 110(2):223–240.
  • Morgan KT, Monticello TM. 1990. Formaldehyde toxicity: respiratory epithelial injury and repair. In: Thomassen DG, Nettesheim P, editors. Biology, toxicology, and carcinogenesis of the respiratory epithelium. Washington (DC): Hemisphere Publishing Corporation.
  • NAS 2011. Review of the Environmental Protection Agency’s draft IRIS assessment of formaldehyde. Washington (DC): U.S. Environmental Protection Agency.
  • Natarajan AT, Darroudi F, Bussman CJ, van Kesteren-van Leeuwen AC. 1983. Evaluation of the mutagenicity of formaldehyde in mammalian cytogenetic assays in vivo and vitro. Mutat Res. 122(3–4):355–360.
  • Neuss S, Zeller J, Ma-Hock L, Speit G. 2010. Inhalation of formaldehyde does not induce genotoxic effects in broncho-alveolar lavage (BAL) cells of rats. Mutat Res. 695(1–2):61–68.
  • NTP 2013. NTP Technical Report on the toxicology studies of tetrabromobisphenol A (CAS no. 79-94-7) in F344/NTac rats and B6C3F1/N mice and toxicology and carcinogenesis studies of tetrabromobisphenol A in Wistar Han [Crl:Wi(Han)] rats and B6C3F1/N mice. NIH Publication no. 14–5929.
  • NTP 2014. Toxicology Studies of Cobalt Metal (CAS No. 7440-48-4) in F344/N Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of Cobalt Metal (CAS No. 7440-48-4) in F344/N Rats and B6C3F1/N Mice (Inhalation Studies). NIH Publication No. 01-4433.
  • O’Brien TJ, Ding H, Suh M, Thompson CM, Parsons BL, Harris MA, Winkelman WA, Wolf JC, Hixon JG, Schwartz AM, et al. 2013. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water. Mutat Res. 754(1–2):15–21.
  • OECD 2013. Guideline for testing of chemicals. 2013. Test guideline 488, - transgenic rodent somatic and germ cell gene mutation assays, adopted July 28. Paris, France: OECD.
  • Pauluhn J. 2003. Issues of dosimetry in inhalation toxicity. Toxicol Lett. 140–141:229–238.
  • Pavkov KL, Kerns WD, Mitchell RI, Connell MM, Donofrio DJ, Harroff HH. 1982. A chronic inhalation toxicology study in rats and mice exposed to formaldehyde. In: Chemical industry institute of toxicology final report. Columbus (OH): Battelle, Columbus Laboratories.
  • Pegg AE. 2011. Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools. Chem Res Toxicol. 24(5):618–639.
  • Pogribny IP, Rusyn I, Beland FA. 2008. Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol Mutagen. 49(1):9–15.
  • Pontel LB, Rosado IV, Burgos-Barragan G, Garaycoechea JI, Yu R, Arends MJ, Chandrasekaran G, Broecker V, Wei W, Liu L, et al. 2015. Endogenous formaldehyde is a hematopoietic stem cell genotoxin and metabolic carcinogen. Mol Cell. 60(1):177–188.
  • Pottenger LH, Boysen G, Brown K, Cadet J, Fuchs RP, Johnson GE, Swenberg JA. 2019. Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions. Environ Mol Mutagen. 60(2):100–121.
  • Preston RJ, Williams GM. 2005. DNA-reactive carcinogens: mode of action and human cancer hazard. Crit Rev Toxicol. 35(8–9):673–683.
  • Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, Schwartz DA, Stamler JS. 2005. Protection from experimental asthma by an endogenous bronchodilator. Science. 308(5728):1618–1621.
  • Rager JE, Moeller BC, Miller SK, Kracko D, Doyle-Eisele M, Swenberg JA, Fry RC. 2014. Formaldehyde-associated changes in microRNAs: tissue and temporal specificity in the rat nose, white blood cells, and bone marrow. Toxicol Sci. 138(1):36–46.
  • Recio L, Sisk S, Pluta L, Bermudez E, Gross EA, Chen Z, Morgan K, Walker C. 1992. p53 mutations in formaldehyde-induced nasal squamous cell carcinomas in rats. Cancer Res. 52(21):6113–6116.
  • Renne R, Brix A, Harkema J, Herbert R, Kittel B, Lewis D, March T, Nagano K, Pino M, Rittinghausen S, et al. 2009. Proliferative and nonproliferative lesions of the rat and mouse respiratory tract. Toxicol Pathol. 37(7 Suppl):5S–73S.
  • Rhomberg LR, Bailey LA, Goodman JE, Hamade AK, Mayfield D. 2011. Is exposure to formaldehyde in air causally associated with leukemia?-A hypothesis-based weight-of-evidence analysis. Crit Rev Toxicol. 41(7):555–621.
  • Rusch GM, Clary JJ, Rinehart WE, Bolte HF. 1983. A 26-week inhalation toxicity study with formaldehyde in the monkey, rat, and hamster. Toxicol Appl Pharmacol. 68(3):329–343.
  • Salk JJ, Schmitt MW, Loeb LA. 2018. Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet. 19(5):269–285.
  • Salthammer T. 2013. Formaldehyde in the ambient atmosphere: from an indoor pollutant to an outdoor pollutant? Angew Chem Int Ed Engl. 52(12):3320–3327.
  • Salthammer T, Mentese S, Marutzky R. 2010. Formaldehyde in the indoor environment. Chem Rev. 110(4):2536–2572.
  • Schlosser PM, Lilly PD, Conolly RB, Janszen DB, Kimbell JS. 2003. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses. Risk Anal. 23(3):473–487.
  • Schroeter JD, Campbell J, Kimbell JS, Conolly RB, Clewell HJ, Andersen ME. 2014. Effects of endogenous formaldehyde in nasal tissues on inhaled formaldehyde dosimetry predictions in the rat, monkey, and human nasal passages. Toxicol Sci. 138(2):412–424.
  • Sellakumar AR, Snyder CA, Solomon JJ, Albert RE. 1985. Carcinogenicity of formaldehyde and hydrogen chloride in rats. Toxicol Appl Pharmacol. 81(3 Pt 1):401–406.
  • Soffritti M, Belpoggi F, Lambertin L, Lauriola M, Padovani M, Maltoni C. 2002. Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats. Ann N Y Acad Sci. 982:87–105.
  • Soffritti M, Maltoni C, Maffei F, Biagi R. 1989. Formaldehyde: an experimental multipotential carcinogen. Toxicol Ind Health. 5(5):699–730.
  • Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, et al. 2001. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol. 34(2):146–152.
  • Speit G, Kuhner S, Linsenmeyer R, Schutz P. 2011. Does formaldehyde induce aneuploidy? Mutagenesis. 26(6):805–811.
  • Speit G, Merk O. 2002. Evaluation of mutagenic effects of formaldehyde in vitro: detection of crosslinks and mutations in mouse lymphoma cells. Mutagenesis. 17(3):183–187.
  • Speit G, Schutz P, Weber I, Ma-Hock L, Kaufmann W, Gelbke HP, Durrer S. 2011. Analysis of micronuclei, histopathological changes and cell proliferation in nasal epithelium cells of rats after exposure to formaldehyde by inhalation. Mutat Res. 721(2):127–135.
  • Speit G, Schmid O, Frohler-Keller M, Lang I, Triebig G. 2007. Assessment of local genotoxic effects of formaldehyde in humans measured by the micronucleus test with exfoliated buccal mucosa cells. Mutat Res. 627(2):129–135.
  • Speit G, Zeller J, Schmid O, Elhajouji A, Ma-Hock L, Neuss S. 2009. Inhalation of formaldehyde does not induce systemic genotoxic effects in rats. Mutat Res. 677(1–2):76–85.
  • Staab CA, Alander J, Brandt M, Lengqvist J, Morgenstern R, Grafstrom RC, Hoog JO. 2008. Reduction of S-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and leads to GSH-controlled formation of glutathione transferase inhibitors. Biochem J. 413(3):493–504.
  • Staab CA, Hellgren M, Hoog JO. 2008. Medium- and short-chain dehydrogenase/reductase gene and protein families : dual functions of alcohol dehydrogenase 3: implications with focus on formaldehyde dehydrogenase and S-nitrosoglutathione reductase activities. Cell Mol Life Sci. 65(24):3950–3960.
  • Stingele J, Bellelli R, Alte F, Hewitt G, Sarek G, Maslen SL, Tsutakawa SE, Borg A, Kjaer S, Tainer JA, et al. 2016. Mechanism and regulation of DNA-protein crosslink repair by the DNA-dependent metalloprotease SPRTN. Mol Cell. 64(4):688–703.
  • Stingele J, Jentsch S. 2015. DNA-protein crosslink repair. Nat Rev Mol Cell Biol. 16(8):455–460.
  • Subramaniam RP, Richardson RB, Morgan KT, Kimbell JS, Guilmette RA. 1998. Computational fluid dynamics simulations of inspiratory airflow in the human nose and nasopharynx. Inhal Toxicol. 10(2):91–120.
  • Swenberg JA, Kerns WD, Mitchell RI, Gralla EJ, Pavkov KL. 1980. Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor. Cancer Res. 40(9):3398–3402.
  • Swenberg JA, Moeller BC, Lu K, Rager JE, Fry RC, Starr TB. 2013. Formaldehyde carcinogenicity research: 30 years and counting for mode of action, epidemiology, and cancer risk assessment. Toxicol Pathol. 41(2):181–189.
  • Takahashi M, Hasegawa R, Furukawa F, Toyoda K, Sato H, Hayashi Y. 1986. Effects of ethanol, potassium metabisulfite, formaldehyde and hydrogen peroxide on gastric carcinogenesis in rats after initiation with N-methyl-N'-nitro-N-nitrosoguanidine. Jpn J Cancer Res. 77(2):118–124.
  • Tan YM, Leonard JA, Edwards S, Teeguarden J, Egeghy P. 2018. Refining the aggregate exposure pathway. Environ Sci Process Impacts. 20(3):428–436.
  • Tang CH, Wei W, Hanes MA, Liu L. 2013. Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition. Cancer Res. 73(9):2897–2904.
  • Teng S, Beard K, Pourahmad J, Moridani M, Easson E, Poon R, O'Brien PJ. 2001. The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chem Biol Interact. 130–132(1–3):285–296.
  • Thomas RS, Allen BC, Nong A, Yang L, Bermudez E, Clewell HJ, Andersen ME. 2007. A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol Sci. 98(1):240–248.
  • Thompson CM. 2018. Commentary on new formaldehyde studies in Trp53 haploinsufficient mice: further support for nonlinear risks from inhaled formaldehyde. Dose Response. 16(2):1559325818777931.
  • Thompson CM, Seiter J, Chappell MA, Tappero RV, Proctor DM, Suh M, Wolf JC, Haws LC, Vitale R, Mittal L, et al. 2015. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water . Toxicol Sci. 143(1):16–25.
  • Thompson CM, Sonawane B, Grafstrom RC. 2009. The ontogeny, distribution, and regulation of alcohol dehydrogenase 3: implications for pulmonary physiology. Drug Metab Dispos. 37(8):1565–1571.
  • Thompson CM, Wolf JC, Elbekai RH, Paranjpe MG, Seiter JM, Chappell MA, Tappero RV, Suh M, Proctor DM, Bichteler A, et al. 2015. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy . Mutat Res Genet Toxicol Environ Mutagen. 789–790:61–66.
  • Thompson CM, Young RR, Dinesdurage H, Suh M, Harris MA, Rohr AC, Proctor DM. 2017. Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue® rats. Toxicol Appl Pharmacol. 330:48–52.
  • Tibbetts AS, Appling DR. 2010. Compartmentalization of Mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr. 30:57–81.
  • Til HP, Woutersen RA, Feron VJ, Hollanders VH, Falke HE, Clary JJ. 1989. Two-year drinking-water study of formaldehyde in rats. Food Chem Toxicol. 27(2):77–87.
  • Tobe M, Naito K, Kurokawa Y. 1989. Chronic toxicity study on formaldehyde administered orally to rats. Toxicology. 56:79–86.
  • Tomasetti C, Vogelstein B. 2015. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 347(6217):78–81.
  • Tweats DJ, Blakey D, Heflich RH, Jacobs A, Jacobsen SD, Morita T, Nohmi T, O'Donovan MR, Sasaki YF, Sofuni T, et al. 2007. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutat Res. 627(1):78–91.
  • U.S. EPA 2005. Guidelines for carcinogen risk assessment, EPA/630/P-03/001F. Risk assessment forum. Washington (DC): U.S. Environmental Protection Agency.
  • U.S. EPA 2007. Framework for determining a mutagenic mode of action for carcinogenicity: using EPA’s 2005 cancer guidelines and supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. Washinton (DC): U.S. Environmental Protection Agency.
  • U.S. EPA 2010. Toxicological review of formaldehyde-inhalation assessment EPA/635/R-10/002A. Washington (DC): U.S. Environmental Protection Agency.
  • U.S. EPA 2017. Guidance to assist interested persons in developing and submitting draft risk evaluations under the toxic substances control act. EPA 740‐R17‐001. Washinton (DC): U.S. Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention.
  • U.S. EPA 2018. Application of systematic review in TSCA risk evaluations. EPA 740‐P1-8001. Washinton (DC): U.S. Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention.
  • U.S. EPA 2019. Proposed designation of formaldehyde (CASRN 50-00-0) as high-priority substance for risk evaluation. Washinton (DC): U.S. Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention
  • Uotila L, Koivusalo M. 1974. Formaldehyde dehydrogenase from human liver. Purification, properties, and evidence for the formation of glutathione thiol esters by the enzyme. J Biol Chem. 249(23):7653–7663.
  • Vaz B, Popovic M, Newman JA, Fielden J, Aitkenhead H, Halder S, Singh AN, Vendrell I, Fischer R, Torrecilla I, et al. 2016. Metalloprotease SPRTN/DVC1 orchestrates replication-coupled DNA-protein crosslink repair. Mol Cell. 64(4):704–719.
  • Walport LJ, Hopkinson RJ, Chowdhury R, Schiller R, Ge W, Kawamura A, Schofield CJ. 2016. Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases. Nat Commun. 7:11974.
  • Wei W, Li B, Hanes MA, Kakar S, Chen X, Liu L. 2010. S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci Transl Med. 2(19):19ra13
  • WHO 2010. WHO guidelines for indoor air quality: selected pollutants. Geneva: WHO.
  • Wood CE, Hukkanen RR, Sura R, Jacobson-Kram D, Nolte T, Odin M, Cohen SM. 2015. Scientific and Regulatory Policy Committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol. 43(6):760–775.
  • Woutersen RA, Kuper CF, Slootweg PJ. 2010. Chronic tissue changes and carcinogenesis in the upper airway. Morris JB, Shusterman DJ, editors. New York (NY): Informa Healthcare.
  • Woutersen RA, van Garderen-Hoetmer A, Bruijntjes JP, Zwart A, Feron VJ. 1989. Nasal tumours in rats after severe injury to the nasal mucosa and prolonged exposure to 10 ppm formaldehyde. J Appl Toxicol. 9(1):39–46.
  • Young R, Dinesdurage H. 2016. Qualification of upper respiratory tract tissues for inhalation exposure of transgenic Big Blue® mice. In 55th Annual Meeting of the Society of Toxicology, New Orleans (LO).
  • Yu G, Chen Q, Liu X, Guo C, Du H, Sun Z. 2014. Formaldehyde induces bone marrow toxicity in mice by inhibiting peroxiredoxin 2 expression. Mol Med Rep. 10(4):1915–1920.
  • Yu GY, Song XF, Zhao SH, Liu Y, Sun ZW. 2015. Formaldehyde induces the bone marrow toxicity in mice by regulating the expression of Prx3 protein. J Huazhong Univ Sci Technolog Med Sci. 35(1):82–86.
  • Yu R, Lai Y, Hartwell HJ, Moeller BC, Doyle-Eisele M, Kracko D, Bodnar WM, Starr TB, Swenberg JA. 2015. Formation, Accumulation, and Hydrolysis of Endogenous and Exogenous Formaldehyde-Induced DNA Damage. Toxicol Sci. 146(1):170–182.
  • Zeller J, Neuss S, Mueller JU, Kuhner S, Holzmann K, Hogel J, Klingmann C, Bruckner T, Triebig G, Speit G. 2011. Assessment of genotoxic effects and changes in gene expression in humans exposed to formaldehyde by inhalation under controlled conditions. Mutagenesis. 26(4):555–561.